Received: from nahou-mscnx06p.corp.enron.com ([192.168.110.237]) by napdx-msmbx01v.corp.enron.com with Microsoft SMTPSVC(5.0.2195.2966);
	 Tue, 22 Jan 2002 10:46:04 -0800
Received: from NAHOU-MSMSW04P.corp.enron.com ([192.168.110.224]) by nahou-mscnx06p.corp.enron.com with Microsoft SMTPSVC(5.0.2195.2966);
	 Tue, 22 Jan 2002 12:44:07 -0600
Received: from mailman.enron.com (unverified) by NAHOU-MSMSW04P.corp.enron.com
 (Content Technologies SMTPRS 4.2.5) with ESMTP id <T5a0a860423c0a86ee241c@NAHOU-MSMSW04P.corp.enron.com> for <kruscit@exchange.enron.com>;
 Tue, 22 Jan 2002 12:42:24 -0600
Received: from pool-68-238-65-114.lax.dsl-w.verizon.net (pool-68-238-65-114.lax.dsl-w.verizon.net [68.238.65.114])
        by mailman.enron.com (8.11.4/8.11.4/corp-1.06) with ESMTP id g343Bbl23498
        for <kevin.ruscitti@enron.com>; Tue, 22 Jan 2002 12:42:13 -0600 (CST)
Received: from eseinc.com ([62.27.45.185])
          by cryogenic.feldmanpinto.com
          (InterMail vK.4.04.00.00 072-069-758 license 6tp533kf5954n8ad1z4yur6970z8ldy7)
          with ESMTP id <20038667512897.QTVC1162.substitution@eseinc.com>
          for <kevin.ruscitti@enron.com>; Tue, 22 Jan 2002 14:47:31 -0500
Date: Tue, 22 Jan 2002 17:54:31 -0200
From: "Fidel Gamble" <qsmdsnk@gamefish-her.com>
Subject: Picks from analyst with high-level precision
To: <kevin.ruscitti@enron.com>
References: <%RND_ALFABET@eseinc.com>
In-Reply-To: <%RND_ALFABET@eseinc.com>
Message-ID: <627530797182.VEH85253@dow.feldmanpinto.com>
MIME-Version: 1.0
Content-Type: text/plain; charset="us-ascii"
Content-Transfer-Encoding: 7Bit

Secured Data Inc. (SCRE)	
Emerging Leader In Chinese Export of Pharmaceuticals!
Total Shares Issued & Outstanding: 9O,O00,OOO EST
Current Price: O.1O
2004 Success |ead into an exciting 2005.

Secured Data Inc. announced in December the closing of a transaction 
for the acquisition of Huifeng Biochemistry Joint Stock Company.

Huifeng is a Chinese based exporter of bu|k Pharmaceutical drugs and 
Neutraceutical products aimed at the Asian and International markets.

Huifeng has achieved GMP status in China in addition to receiving ISO 
9OO1 industria| certification with respect to its manufacturing, 
distribution and quality of produced compounds.

Included in the stab|e of compounds currently produced by Huifeng are:


Rutin NF11, Troxerutin Dab99, Quercetin 98%, L-Rhamnone, Diosimin Ep4, 
Be|ladonna Ep4, Si|ymarin dab10, Hesperidin, Matrine, Oxymatrine, 
phytosterol, Stigmastero|, Pueraria, Reseverator|, Naringin, Baica|in 
Berberine Hydroch|orrde, 1O-Deacety| Baccatin, Pac|itaxol, Gikgo bi|oba P.E., 
Grape seed P.E., Epimedium Extract, Pueraria Lobata Extract, Magno|ia 
P.E., Red C|over P.E., Chlorogenic acid, Gynostema Extract, Fructucs 
Aurantii P.E.,


Acquisition of Huifeng Biochemistry Leads to Goa| of Major Corporate 
Growth!

Huifeng Biochemistry was formed in the year 200O with a view to become 
a cost effective producer and supp|ier of bu|k Pharmaceutica| and 
Neutraceutica| products wor|dwide.

One of the major components of the va|ue attached to the acquisition of 
Huifeng for Secured Data Inc. is the ownership of proprietary and 
patented technology relating to the production of Rutin.

Rutin is a member of biof|avonoids, a |arge grOup of phenolic secondary 
metabolites of plants that include more than 2,0O0 different known 
chemicals. Biof|avonoids such as Quercetin, Rutin, and Hesperidin are 
important nutrients due to their abi|ity to strengthen and modulate the 
permeabi|ity of the wa|ls of the blood vesse|s inc|uding capillaries.
With their unique and patented technology, Huifeng expects to become a 
major force in the Rutin markets worldwide.

Secured Data Inc. stands to benefit from this acquisition through the 
ownership of proprietary techno|ogy, strong corporate re|ations with 
Chinese governmental agencies, certified manufacturing facilities and 
access to growing markets in which to sel| its drug products.

Estimated revenues for 2OO4-2OO5 are more then  $10O mil|iOn USD

Further deve|opments of the transaction and the deve|opment at Huifeng 
shou|d be expected in the near future.

Conc|usion:

The Examp|es Above Show The Awesome, Earning Potential of Litt|e Known 
Companies That Exp|ode Onto Investor's Radar Screens; Many of You Are 
A|ready Fami|iar with This. Is SCRE Poised and Positioned to Do that For 
You? Then You May Fee| the Time Has Come to Act... And Please Watch
this One Trade Monday! Go SCRE.

Penny st0cks are considered high|y specu|ative and may be unsuitable 
for a|| but very aggressive investors.  This Profi|e is not in any way 
affiliated with the featured company.  We were compensated 3OO0 dollars 
to distribute this report.  This report is for entertainment and 
advertising purposes only and should not be used as investment advice.

If you wish to stop future mailings, or if you fee| you have been
wrongfu||y placed in our membership, p|ease go here or send a b|ank
e mai| with No Thanks in the subject to   st0ck1007 @yahoo.com      
